Atherosclerotic risk factor reduction in peripheral arterial diseasea: results of a national physician survey
about
Emerging drugs in peripheral arterial diseasePeripheral artery disease: current insight into the disease and its diagnosis and management.Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease.Secondary Pharmacotherapeutic Prevention among German Primary Care Patients with Peripheral Arterial Disease.Suboptimal use of risk reduction therapy in peripheral arterial disease patients at a major teaching hospitalActivating peripheral arterial disease patients to reduce cholesterol: a randomized trialVascular Disease and Risk Stratification for Ischemic Stroke and All-Cause Death in Heart Failure Patients without Diagnosed Atrial Fibrillation: A Nationwide Cohort Study.Atherosclerotic disease and risk factor modification in Saudi Arabia: a call to action.Efficacy of optimal long-term management of multiple cardiovascular risk factors (CVD) on walking and quality of life in patients with peripheral artery disease (PAD): protocol for randomized controlled trialThe Group Oriented Arterial Leg Study (GOALS) to improve walking performance in patients with peripheral arterial disease.Process of care and outcomes in patients with peripheral arterial diseaseKnowledge and attitude of physicians in a major teaching hospital towards atherosclerotic risk reduction therapy in patients with peripheral arterial disease.Impact of critical limb ischemia on long-term cardiac mortality in diabetic patients undergoing percutaneous coronary revascularization.Plasma levels of soluble Tie2 and vascular endothelial growth factor distinguish critical limb ischemia from intermittent claudication in patients with peripheral arterial disease.Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosisA review of simple, non-invasive means of assessing peripheral arterial disease and implications for medical management.ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures, the American College of RAttitudes and behavior of peripheral arterial disease patients toward influencing their physician's prescription of cholesterol-lowering medication.Home-based walking exercise intervention in peripheral artery disease: a randomized clinical trial.Poor knowledge of peripheral arterial disease among the Saudi population: A cross-sectional study.Peripheral arterial disease is prevalent but underdiagnosed and undertreated in the primary care setting in central Greece.Cardiovascular risk factor management is poorer in diabetic patients with undiagnosed peripheral arterial disease than in those with known coronary heart disease or cerebrovascular disease. Results of a nationwide study in tertiary diabetes centres.Internal medicine interns have a poor knowledge of peripheral artery disease.Outcomes and risk prediction model for peripheral arterial disease in patients with stable coronary artery disease.
P2860
Q28195408-364FFC7E-1C20-487F-9693-3E86183C32B5Q33951581-886FE8F8-0914-4AA8-A1E3-3914AB4764B4Q34297015-F90CB026-7153-4466-A1D4-5D3CC77C96C5Q35073032-E47D0723-1282-4E2D-9726-1AE75D4555E2Q35165801-501194F8-0946-4D56-9059-B8B34DFAC11DQ35578292-2CC11D07-690A-4B2B-A9DC-AC692A7A7F21Q35970469-CA76505F-E34D-4AC0-B541-4B09A93EEA37Q36027227-C38D0BDC-99C8-45C9-8FE1-B6101ACE615CQ36119712-E52130E2-C7BB-4891-9E6A-06682E94799EQ36413783-7A6E7427-8E8B-41BF-8348-BE0D8BBF3B66Q36416691-D44973DB-2E60-44ED-8912-26E1B22DF201Q36596899-6C8D6BEE-256E-45EA-8C25-DD7FB500FD08Q36868203-33D0D29D-8D85-46AB-A832-52A60A3D560EQ37097986-C1E8BBCF-A2C1-4210-97AD-FE414E447D84Q37596406-383C190C-0389-4081-B5A2-DC365B34B675Q37692405-425EF7B4-F1D9-4A93-A8CF-97C48F89D605Q37823798-95A341CE-1F12-46DA-B8C6-BC3C16DE968FQ38376050-F815D42C-F891-4BDF-BE0A-D293123E4A6EQ38448981-2A23A19C-BB32-44BE-AD1B-CF6FA00369FBQ39767092-9878FADD-16B6-4793-8A5A-A7C5C6FE9BE0Q43729857-4EB507FE-D227-410E-8B3B-FE17CD01EAD9Q46701536-386A9F53-A58B-4209-B2C0-9FD2DF5617C6Q50970365-DF3B7532-E9F1-4C0E-92B4-9ACC55F18217Q51019211-640D1194-B376-40B6-82AC-BE80EEF49673
P2860
Atherosclerotic risk factor reduction in peripheral arterial diseasea: results of a national physician survey
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Atherosclerotic risk factor re ...... of a national physician survey
@ast
Atherosclerotic risk factor re ...... of a national physician survey
@en
Atherosclerotic risk factor re ...... of a national physician survey
@nl
type
label
Atherosclerotic risk factor re ...... of a national physician survey
@ast
Atherosclerotic risk factor re ...... of a national physician survey
@en
Atherosclerotic risk factor re ...... of a national physician survey
@nl
prefLabel
Atherosclerotic risk factor re ...... of a national physician survey
@ast
Atherosclerotic risk factor re ...... of a national physician survey
@en
Atherosclerotic risk factor re ...... of a national physician survey
@nl
P2093
P2860
P1476
Atherosclerotic risk factor re ...... of a national physician survey
@en
P2093
Alan T Hirsch
David Cella
Donna Brogan
Elizabeth A Hahn
Judith K Ockene
Kendra Hanley
Linda Odom
Martin S Lipsky
Mary McGrae McDermott
Philip Greenland
P2860
P304
P356
10.1046/J.1525-1497.2002.20307.X
P577
2002-12-01T00:00:00Z
P5875
P6179
1036615030